Literature DB >> 18177720

Bone remodeling, energy metabolism, and the molecular clock.

Clifford J Rosen1.   

Abstract

The adult skeleton is constantly renewed through bone remodeling. Four recent papers (Baldock et al., 2007; Lee et al., 2007; Lundberg et al., 2007; Sato et al., 2007) provide new insights into central and peripheral control of this remodeling sequence. Two of the studies add to our knowledge of the complex hypothalamic modulation of bone turnover mediated by NMU and NPY via the sympathetic nervous system, while the other two focus on the peripheral neural target, the osteoblast, and its regulation by neuropeptides and osteocalcin. These findings support a new paradigm concerning the regulation of bone remodeling and provide a foundation for novel approaches to preventing osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18177720     DOI: 10.1016/j.cmet.2007.12.004

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  40 in total

1.  Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice.

Authors:  Ganesh V Halade; Amina El Jamali; Paul J Williams; Roberto J Fajardo; Gabriel Fernandes
Journal:  Exp Gerontol       Date:  2010-10-12       Impact factor: 4.032

2.  Building bones by knocking down genes.

Authors:  Clifford J Rosen
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

Review 3.  Minireview: A skeleton in serotonin's closet?

Authors:  Masanobu Kawai; Clifford J Rosen
Journal:  Endocrinology       Date:  2010-07-21       Impact factor: 4.736

4.  Ablation of systemic phosphate-regulating gene fibroblast growth factor 23 (Fgf23) compromises the dentoalveolar complex.

Authors:  E Y Chu; H Fong; F A Blethen; K A Tompkins; B L Foster; K D Yeh; K J Nagatomo; D Matsa-Dunn; D Sitara; B Lanske; R B Rutherford; M J Somerman
Journal:  Anat Rec (Hoboken)       Date:  2010-07       Impact factor: 2.064

Review 5.  Emerging therapeutic opportunities for skeletal restoration.

Authors:  Masanobu Kawai; Ulrike I Mödder; Sundeep Khosla; Clifford J Rosen
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

Review 6.  The multiple faces of autoimmune-mediated bone loss.

Authors:  Georg Schett; Jean-Pierre David
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

7.  A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis.

Authors:  Paul D Miller
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-12       Impact factor: 5.346

8.  Skeletal aging and the adipocyte program: New insights from an "old" molecule.

Authors:  Beata Lecka-Czernik; Clifford J Rosen; Masanobu Kawai
Journal:  Cell Cycle       Date:  2010-09-15       Impact factor: 4.534

Review 9.  Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep.

Authors:  Christine M Swanson; Steven A Shea; Katie L Stone; Jane A Cauley; Clifford J Rosen; Susan Redline; Gerard Karsenty; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

10.  The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity.

Authors:  Eiichi Hinoi; Nan Gao; Dae Young Jung; Vijay Yadav; Tatsuya Yoshizawa; Martin G Myers; Streamson C Chua; Jason K Kim; Klaus H Kaestner; Gerard Karsenty
Journal:  J Cell Biol       Date:  2008-12-22       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.